Bhatt Elizabeth
Insider CIK 1748622 · AKAO Chief Operating Officer · AMTI Chief Bus. & Strategy Officer · LWAC Director · SEPN President and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SEPN Septerna, Inc. | M Exercise deriv | 2026-10-15 | 2026-10-19 | 4,000 | — | $0 | 58,230 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-10-15 | 2026-10-19 | 2,906 | $37.61 | $109.3K | 174,209 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-10-15 | 2026-10-19 | 1,094 | $36.87 | $40.3K | 177,115 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-10-15 | 2026-10-19 | 4,000 | $6.81 | $27.2K | 178,209 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise deriv | 2026-08-11 | 2026-08-13 | 18,681 | — | $0 | 62,230 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise deriv | 2026-08-11 | 2026-08-13 | 6,319 | — | $0 | 82,332 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-08-11 | 2026-08-13 | 6,319 | $2.76 | $17.4K | 199,209 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-11 | 2026-08-13 | 25,000 | $44.00 | $1.10M | 174,209 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-08-11 | 2026-08-13 | 18,681 | $6.81 | $127.2K | 192,890 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise deriv | 2026-08-11 | 2026-08-13 | 6,319 | — | $0 | 82,332 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise deriv | 2026-08-11 | 2026-08-13 | 18,681 | — | $0 | 62,230 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-11 | 2026-08-13 | 25,000 | $44.00 | $1.10M | 174,209 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-08-11 | 2026-08-13 | 6,319 | $2.76 | $17.4K | 199,209 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-08-11 | 2026-08-13 | 18,681 | $6.81 | $127.2K | 192,890 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise deriv | 2026-07-15 | 2026-07-17 | 4,000 | — | $0 | 80,911 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-07-15 | 2026-07-17 | 4,000 | $6.81 | $27.2K | 178,209 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-07-15 | 2026-07-17 | 4,000 | $33.99 | $136.0K | 174,209 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise deriv | 2026-04-15 | 2026-04-17 | 4,000 | — | $0 | 84,911 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-04-15 | 2026-04-17 | 1,101 | $25.24 | $27.8K | 174,535 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-04-15 | 2026-04-17 | 4,000 | $6.81 | $27.2K | 178,209 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-04-15 | 2026-04-17 | 326 | $25.86 | $8.4K | 174,209 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-04-15 | 2026-04-17 | 2,573 | $23.76 | $61.1K | 175,636 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise deriv | 2026-02-18 | 2026-02-20 | 4,000 | — | $0 | 88,911 | SEC↗ |
| SEPN Septerna, Inc. | M Exercise | 2026-02-18 | 2026-02-20 | 4,000 | $6.81 | $27.2K | 178,209 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-02-18 | 2026-02-20 | 2,200 | $28.46 | $62.6K | 176,009 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-02-18 | 2026-02-20 | 1,800 | $29.58 | $53.2K | 174,209 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2026-02-06 | 2026-02-10 | 155,000 | — | $0 | 155,000 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2025-08-07 | 2025-08-11 | 95,000 | — | $0 | 95,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-06-13 | 2024-06-13 | 800 | — | $0 | 800 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-02-19 | 2024-02-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-06-22 | 2023-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-01-20 | 2023-01-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-06-09 | 2022-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award deriv | 2022-02-15 | 2022-02-16 | 80,500 | — | $0 | 80,500 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award | 2022-02-15 | 2022-02-16 | 17,250 | — | $0 | 48,750 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award | 2021-12-24 | 2022-01-06 | 31,500 | — | $0 | 31,500 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-10-06 | 2021-10-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | C Conversion deriv | 2021-08-25 | 2021-08-27 | 9,047 | — | $0 | 0 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | D To issuer deriv | 2021-08-25 | 2021-08-27 | 8,453 | — | $0 | 8,453 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | C Conversion | 2021-08-25 | 2021-08-27 | 9,047 | — | $0 | 9,047 | SEC↗ |
| AMTI Applied Molecular Transpor | M Exercise deriv | 2021-07-21 | 2021-07-22 | 9,000 | — | $0 | 292,632 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-07-21 | 2021-07-22 | 6,640 | $36.41 | $241.8K | 2,360 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-07-21 | 2021-07-22 | 2,360 | $37.43 | $88.3K | 0 | SEC↗ |
| AMTI Applied Molecular Transpor | M Exercise | 2021-07-21 | 2021-07-22 | 9,000 | $4.61 | $41.5K | 9,000 | SEC↗ |
| AMTI Applied Molecular Transpor | M Exercise deriv | 2021-04-21 | 2021-04-22 | 9,000 | — | $0 | 301,632 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-04-21 | 2021-04-22 | 971 | $39.30 | $38.2K | 8,029 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-04-21 | 2021-04-22 | 5,417 | $40.38 | $218.7K | 2,612 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-04-21 | 2021-04-22 | 2,612 | $41.21 | $107.6K | 0 | SEC↗ |
| AMTI Applied Molecular Transpor | M Exercise | 2021-04-21 | 2021-04-22 | 9,000 | $4.61 | $41.5K | 9,000 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award deriv | 2021-03-01 | 2021-03-03 | 63,000 | — | $0 | 63,000 | SEC↗ |
| LWAC Locust Walk Acquisition Co | J Other deriv | 2021-01-12 | 2021-01-14 | 17,500 | — | $0 | 17,500 | SEC↗ |
| AKAO Achaogen, Inc. | S Sale | 2019-02-21 | 2019-02-25 | 971 | $0.89 | $864 | 238,155 | SEC↗ |
| AKAO Achaogen, Inc. | A Award | 2019-01-18 | 2019-01-23 | 156,500 | — | $0 | 239,126 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2018-09-11 | 2018-09-13 | 65,000 | — | $0 | 65,000 | SEC↗ |